News Release- Attentive Science Expands to Abu Dhabi, UAE.

Masdar City, Abu Dhabi 31st May 2024 - Continuing with its global strategy, Attentive Science, a pioneering leader in nonclinical drug development services, proudly announces its expansion into the emerging market of Abu Dhabi, UAE. With a relentless commitment to excellence and a proven track record in delivering cutting-edge solutions, this expansion marks a pivotal moment in the company's journey as it continues to provide unparalleled nonclinical Contract Research services worldwide.

The facilities of Attentive Science in Abu Dhabi are situated within Masdar City, designated by the Abu Dhabi Department of Health (DOH) as the national hub for Life Sciences. Spanning over 50,000 square feet, the Masdar City facilities of Attentive Science will provide a spectrum of services from early discovery through regulated toxicology and safety studies. These operations will adhere to both local and international regulations and standards. Focused on drug development services conducted in accordance with Good Laboratory Practices (GLP), Attentive Science is poised to establish itself as the leading provider in the region within this field.

Attentive Science Abu Dhabi will begin offering In-Vitro Services as soon as September of this year while a dedicated custom building is constructed with a target date of operation at end of 2025. The completed facility will provide critical services including hosting companies in its facilities and with a focus on large molecules, cell, gene, and immune therapy drug development services.  Tareq Abu-Nadi, CEO and Co-Founder of the Abu Dhabi location said, “We are delighted to witness the fruition of careful planning. The inviting and very active support of the Abu Dhabi DOH was the deciding factor in selecting Abu Dhabi out of multiple options in the region. The Life science ecosystem is rapidly growing in Abu Dhabi making it one of the most attractive areas promoting research and innovation."

Dr. Namir Shaabani, CSO and Co-Founder, added, "Our expansion into Abu Dhabi is a testament to our commitment to advancing global health through cutting-edge research and collaboration. By establishing a robust presence in Masdar City, we aim to not only provide critical nonclinical research services but also foster a thriving environment for innovation and early-stage start-ups."

“The collaborative spirit of the Abu Dhabi DOH presented Attentive Science with a very unique opportunity as it explored its global expansion and potential partnerships, said Dr Alfred Botchway, Co-Founder of the Abu Dhabi location and Board Chair, Attentive Science.”  By providing our research services globally, Attentive Science is well positioned to continue to support the pharmaceutical, biotechnology, animal health and agrochemical industries.

For more information about Attentive Science and its range of solutions, please visit or contact

Where Did The Blood Pressure Go – Cardiovascular Safety Pharmacology